Seiji Mabuchi Selected Research

N- (2,5- bis(trifluoromethyl)phenyl)- 5- bromo- 2- hydroxybenzamide

5/2016

The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Mabuchi Research Topics

Disease

63	Neoplasms (Cancer) 04/2022 - 04/2006
56	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 05/2009
31	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2002
16	Carcinoma (Carcinomatosis) 11/2021 - 03/2007
9	Ovarian Epithelial Carcinoma 01/2021 - 10/2012
9	Adenocarcinoma 05/2020 - 09/2010
9	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2011
6	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 05/2013
6	Ascites 01/2015 - 05/2004
3	Margins of Excision 12/2021 - 10/2017
3	Inflammation (Inflammations) 01/2021 - 11/2013
3	Breast Neoplasms (Breast Cancer) 03/2019 - 10/2003
3	Disease Progression 01/2018 - 04/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 04/2010
3	Carcinogenesis 05/2016 - 10/2003
2	Fistula 04/2022 - 03/2021
2	Leukocytosis (Pleocytosis) 01/2019 - 07/2011
2	Thrombocytosis (Thrombocythemia) 01/2019 - 11/2015
2	Adenosquamous Carcinoma 03/2017 - 10/2012
2	Osteoporosis 01/2017 - 01/2009
2	Chorioamnionitis 03/2016 - 11/2013
2	Lymphatic Metastasis 12/2015 - 01/2011
2	Hypoxia (Hypoxemia) 05/2015 - 09/2009
2	Colorectal Neoplasms (Colorectal Cancer) 03/2010 - 02/2010
2	Hematologic Neoplasms (Hematological Malignancy) 03/2010 - 02/2010
1	Gastrointestinal Hemorrhage (Hematochezia) 04/2022
1	Hemorrhagic Shock 04/2022
1	Anemia 01/2022
1	Fatigue 01/2022
1	Uterine Cervical Dysplasia 01/2022
1	Vulvar Neoplasms (Vulvar Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

13	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 04/2010
13	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 03/2004
12	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2002
10	Indicators and Reagents (Reagents)IBA 12/2021 - 07/2011
8	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 05/2009
7	PlatinumIBA 10/2019 - 05/2009
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 03/2007
6	Estrogens (Estrogen)FDA Link 03/2019 - 10/2003
6	nedaplatinIBA 08/2015 - 12/2009
5	Bevacizumab (Avastin)FDA Link 04/2022 - 12/2008
5	Biological ProductsIBA 03/2019 - 03/2004
4	TOR Serine-Threonine KinasesIBA 12/2020 - 03/2007
4	Estrogen ReceptorsIBA 03/2019 - 01/2004
4	Neutralizing AntibodiesIBA 03/2019 - 07/2014
4	Pharmaceutical PreparationsIBA 01/2019 - 12/2009
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2014
4	MicroRNAs (MicroRNA)IBA 11/2018 - 05/2013
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015 - 09/2002
4	Everolimus FDA Link 07/2011 - 03/2007
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2015
3	Raloxifene Hydrochloride (Evista)FDA Link 01/2017 - 10/2003
3	Phosphotransferases (Kinase)IBA 05/2016 - 01/2002
3	Monoclonal AntibodiesIBA 03/2010 - 12/2008
2	Dinoprostone (PGE2)FDA Link 12/2020 - 11/2018
2	PM 01183IBA 10/2019 - 01/2016
2	Celecoxib (Celebrex)FDA Link 01/2019 - 11/2018
2	VitronectinIBA 11/2018 - 10/2017
2	perifosineIBA 12/2017 - 04/2015
2	taxaneIBA 12/2017 - 05/2009
2	IntegrinsIBA 10/2017 - 05/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 05/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2016 - 01/2002
2	CytokinesIBA 03/2016 - 11/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 12/2009
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2015 - 11/2013
2	TrabectedinIBA 06/2014 - 07/2011
2	AntigensIBA 03/2010 - 02/2010
2	BAY 11-7085IBA 11/2004 - 05/2004
2	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2004 - 10/2003
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2022
1	ninjin'yoeitoIBA 01/2022
1	IronIBA 01/2022
1	plitidepsin (aplidine)IBA 09/2021
1	C-Reactive ProteinIBA 01/2021
1	AlbuminsIBA 01/2021
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2020
1	B7-H1 AntigenIBA 12/2020
1	Dihydrotachysterol (AT 10)IBA 05/2020
1	SuspensionsIBA 01/2020

Therapy/Procedure

28	Radiotherapy 12/2021 - 05/2009
20	Therapeutics 01/2022 - 01/2008
18	Drug Therapy (Chemotherapy) 04/2022 - 05/2009
16	Hysterectomy 04/2022 - 11/2011
12	Chemoradiotherapy 11/2020 - 12/2009
7	Brachytherapy 03/2019 - 01/2010
6	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 10/2012
5	Adjuvant Radiotherapy 03/2013 - 11/2011
3	Aftercare (After-Treatment) 01/2022 - 02/2015
3	Traction 01/2021 - 01/2020
3	Salvage Therapy 11/2016 - 10/2013
3	Cytoreduction Surgical Procedures 06/2014 - 03/2010
2	Kampo Medicine (Kampo) 01/2022 - 01/2018
2	Trachelectomy 03/2019 - 01/2017
2	Consolidation Chemotherapy 01/2017 - 05/2016
2	Splenectomy 12/2015 - 07/2014
1	Salpingo-oophorectomy 04/2022
1	Laser Therapy (Surgery, Laser) 01/2022
1	Adjuvant Chemotherapy 05/2020